01WE DOCUMENT, THEN AUTOMATE
The Vant operating playbook becomes a living document. Then it runs itself.
01WE OBSERVE
02WE DOCUMENT
03WE AUTOMATE
04YOU CORRECT
×RoivantThe operating layer underneath every Vant — and the consolidation across them.
AcrossImmunovantPriovantPulmovantKinevantHemavantGenevantVantAI
OBSERVED · LIVE
tenants 142/142
PHY-OBS · v3
2026-05-07 09:14:02Z
SAP · invoice #48201 observed·RULE R-04 applied · accrual lag·AGENT close.mar26 resolved 47 / 48·EXPERT e.maguire corrected map → spec sharpened·SAP · invoice #48201 observed·RULE R-04 applied · accrual lag·AGENT close.mar26 resolved 47 / 48·EXPERT e.maguire corrected map → spec sharpened·
Deployed with the world's largest private company.
LIFE AT ROIVANT WITH PHYVANT
Every Vant connected. Every intercompany flow live. Every divestiture closed without a six-month TSA.
02ONE QUERYABLE SURFACE
Every Vant, every entity, every intercompany — on one graph.
Per-Vant GLsRoivant corporate ERPWorkday / HRISClinical trial systems
PHYVANT GRAPH
Cash runway by Vant, live, against current burnIntercompany position by Vant, this quarter to date
WHY ROIVANT
The Vant model is the strategy. The back office has to scale with it.
01
Multi-subsidiary, by design
Each Vant — own entity, own CEO, own books. On purpose. Intercompany is the default, not the edge case.
ORG CHART · LIVE
+ TelavantTelavant → Roche · $7.1B+ Pulmovant+ KinevantDermavant → Organon+ HemavantSumitovant JV · 5 Vants+ Affivant+ Lokavant+ VantAI+ TelavantTelavant → Roche · $7.1B+ Pulmovant+ KinevantDermavant → Organon+ HemavantSumitovant JV · 5 Vants+ Affivant+ Lokavant+ VantAI
+ TelavantTelavant → Roche · $7.1B+ Pulmovant+ KinevantDermavant → Organon+ HemavantSumitovant JV · 5 Vants+ Affivant+ Lokavant+ VantAI+ TelavantTelavant → Roche · $7.1B+ Pulmovant+ KinevantDermavant → Organon+ HemavantSumitovant JV · 5 Vants+ Affivant+ Lokavant+ VantAI
02
The org chart never holds still
Telavant → Roche. Dermavant → Organon. Sumitovant for five. Every quarter a new entity, a new TSA, a new tail.
ROIVANT CORP · SHARED SERVICES100%
IMVT
22%
PRIO
17%
PULM
13%
KINE
10%
GENE
11%
HEMA
9%
VANTAI
10%
OTHER
8%
03
Allocations the auditors will sign
Corp shared services split across every Vant on rules that hold up to auditors, the board, and Sumitomo.
PER-VANT GLs
→
ROIV · 10-Q
04
A dozen-plus Vants → one ROIV
The quarterly 10-Q rollup stops being a fire drill. It becomes a query.
RUN THESE ON YOUR DATA
What Phyvant can do for Roivant
01
Cash runway and burn by Vant — consolidated, live, across every entity
Each Vant has its own monthly burn, its own cash position, and its own runway against the next clinical readout. Today that lives in a board deck assembled by hand each quarter. Phyvant pulls it from each Vant's GL into one queryable rollup — and holds it against the corporate cash position, intercompany funding commitments, and the next milestone window.
Corporate FP&A / Burn & Runway by VantLIVE
Monthly Burn — Active Vants
Live monthly burn by Vant against committed corporate funding. Late-stage Vants concentrate the spend; preclinical Vants consume the option value.
Late-stage clinicalMid-stage clinicalPreclinical / discovery
Q1
Q2
Q3
Q4
Q1+
Q2+
Ask: which Vants have less than 18 months of runway against current burn…Open runway packet
02
Deal-economics waterfall — every milestone, royalty, and deferred payment, on cadence
Telavant to Roche. Dermavant to Organon. Sumitovant joint-venture economics on five legacy Vants. Each deal carries its own milestone schedule, royalty tier, and accrual convention. Phyvant tracks every contractual trigger against current clinical and commercial state — and trues up the accrual the moment the trigger hits, not at quarter-end.
Deal Economics / Milestone & Royalty TrackerLIVE
Active Deal-Economics Tails — Live
Every active deal-economics tail across Roivant's exit history, mapped to its current trigger state and accrual posture.
Counterparty
Vant
Structure
Next trigger
Accrual status
Roche
Telavant
Upfront + milestone
P3 readout window
Tracked
Organon
Dermavant
Upfront + sales milestones
Vtama net-sales tier
Trued up
Sumitomo / Sumitovant
Five-Vant JV
Earnout + royalty
Quarterly true-up
On cadence
Pfizer (legacy)
Priovant
Brepocitinib license
Indication milestone
Open
Ask: which deal-economics triggers are likely to hit before fiscal year-end…Open deal-economics packet
03
Every Vant's operating stack on the corporate surface — without a per-Vant migration
Each Vant onboarded on whatever stack made sense at the time. Some run on a lightweight cloud GL with a few seats. Some inherited a stack from a Sumitovant-era restructuring. New Vants stand up in weeks. Phyvant pulls budget, headcount, vendor spend, and clinical-ops state from each Vant's native stack — regardless of where any IT consolidation sits — and exposes it on the corporate surface.
Per-Vant Operations / Live SurfaceLIVE
Active Vants — Operating Integration Status
Phyvant pulls operating data from each Vant's native stack and exposes it on the corporate surface. New Vants come online in weeks, not quarters.
Vant
Stage
Native GL
Budget vs. actual
Intercompany
Headcount roll-up
Immunovant
Public / late-stage
NetSuite
Live
Live
Live
Priovant
Late-stage clinical
NetSuite
Live
Live
Live
Pulmovant
Mid-stage clinical
QuickBooks
Live
Live
Live
Kinevant
Mid-stage clinical
QuickBooks
Live
Live
Live
Hemavant
Early clinical
QuickBooks
Live
Partial
Live
Genevant
Platform / royalty
NetSuite
Live
Live
Live
VantAI
Discovery
Modern stack
Live
Live
Live
Ask: consolidated headcount and shared-service allocation across all Vants this quarter…Open Vant operating packet
COMMON AUTOMATION WORKFLOWS
↦
Per-Vant budget vs. actual on cadence
Each Vant's burn, headcount, and vendor spend pulled from its native GL — rolled up to corporate every period.
◆
Intercompany allocation & true-up
Shared-service allocations from Roivant corp to every Vant — defensible to auditors, the board, and Sumitomo, with the rule documented.
⇄
Milestone-driven accrual
Telavant, Dermavant, Sumitovant deal-economics triggers monitored against current clinical and commercial state — accrual posted the moment the trigger hits.
◇
Divestiture / TSA closeout
When a Vant exits, the TSA service catalog, intercompany unwind, and IPR&D treatment are documented in advance and run from that document.
PROOF
Built for operators where intercompany complexity is the strategy, not the legacy.
99.8%
Production uptime
97%
Accuracy after 6 months
99.9%
Reduction in audit response time